The Effect of Atorvastatin on the NO-system in Patients With Type 2 Diabetes and Nephropathy.
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2015
At a glance
- Drugs Atorvastatin (Primary)
- Indications Diabetic nephropathies
- Focus Pharmacodynamics
- Acronyms STAD
- 07 Jun 2017 Biomarkers information updated
- 18 Dec 2013 Last checked against European clinical trials database.
- 30 Jan 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.